Impact of thyroid function screening in a large cohort of patients admitted to an emergency department.


Journal

Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418

Informations de publication

Date de publication:
11 2022
Historique:
received: 28 03 2022
accepted: 28 07 2022
pubmed: 26 8 2022
medline: 16 11 2022
entrez: 25 8 2022
Statut: ppublish

Résumé

Thyroid dysfunctions are highly prevalent and can worsen underlying cardiopathies, but despite that the routine screening of thyroid function in the Emergency Department (ED) setting is not generally recommended. To understand if staff training and implementation of rapid TSH screening (rTSH) could improve the management of patients arrived in the ED. Specifically, we aimed at evaluating the prevalence of undiagnosed thyroid diseases among ED patients; the effects of educational meetings in the clinical decision-making process; the usefulness of rTSH, in terms of variation of either the clinical work out or the existing treatment. Retrospective case-control study of 9227 patients managed in the ED of an academic institution. rTSH was routinely available for all patients, who were divided into rTSH-YES and rTSH-NO groups. We included 4243 and 4984  patients in the rTSH-YES and rTSH-NO group, respectively. Trained personnel uncovered a high prevalence of undiagnosed thyroid dysfunction (7%). The diagnosis in the ED of heart failure, history of thyroid diseases, contrast media/amiodarone administration and female gender were independently associated with an increased likelihood to have thyroid dysfunction. The rTSH improved the clinical outcome by (a) appropriate treatment of an underlying clinical condition causing ED entrance, (b) appropriate prophylaxis in patients requiring contrast media, (c) uncovering incorrect treatments, with 60% of patients on levothyroxine requiring a dose reduction. The rTSH in the ED revealed a high prevalence of untreated thyroid disorders with a major impact on following interventions. The training of a multidisciplinary team is crucial in driving the correct decision-making process.

Sections du résumé

BACKGROUND
Thyroid dysfunctions are highly prevalent and can worsen underlying cardiopathies, but despite that the routine screening of thyroid function in the Emergency Department (ED) setting is not generally recommended.
OBJECTIVE
To understand if staff training and implementation of rapid TSH screening (rTSH) could improve the management of patients arrived in the ED. Specifically, we aimed at evaluating the prevalence of undiagnosed thyroid diseases among ED patients; the effects of educational meetings in the clinical decision-making process; the usefulness of rTSH, in terms of variation of either the clinical work out or the existing treatment.
DESIGN
Retrospective case-control study of 9227 patients managed in the ED of an academic institution. rTSH was routinely available for all patients, who were divided into rTSH-YES and rTSH-NO groups.
RESULTS
We included 4243 and 4984  patients in the rTSH-YES and rTSH-NO group, respectively. Trained personnel uncovered a high prevalence of undiagnosed thyroid dysfunction (7%). The diagnosis in the ED of heart failure, history of thyroid diseases, contrast media/amiodarone administration and female gender were independently associated with an increased likelihood to have thyroid dysfunction. The rTSH improved the clinical outcome by (a) appropriate treatment of an underlying clinical condition causing ED entrance, (b) appropriate prophylaxis in patients requiring contrast media, (c) uncovering incorrect treatments, with 60% of patients on levothyroxine requiring a dose reduction.
CONCLUSIONS
The rTSH in the ED revealed a high prevalence of untreated thyroid disorders with a major impact on following interventions. The training of a multidisciplinary team is crucial in driving the correct decision-making process.

Identifiants

pubmed: 36008599
doi: 10.1007/s11739-022-03071-0
pii: 10.1007/s11739-022-03071-0
doi:

Substances chimiques

Contrast Media 0
Thyrotropin 9002-71-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2379-2389

Informations de copyright

© 2022. The Author(s), under exclusive licence to Società Italiana di Medicina Interna (SIMI).

Références

Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, Okosieme OE (2018) Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol 14:301–316. https://doi.org/10.1038/nrendo.2018.18
doi: 10.1038/nrendo.2018.18 pubmed: 29569622
Biondi B, Cooper DS (2008) The clinical significance of subclinical thyroid dysfunction. Endocr Rev 29:76–131. https://doi.org/10.1210/er.2006-0043
doi: 10.1210/er.2006-0043 pubmed: 17991805
von Hafe M, Neves JS, Vale C, Borges-Canha M, Leite-Moreira A (2019) The impact of thyroid hormone dysfunction on ischemic heart disease. Endocr Connect 8:R76–R90. https://doi.org/10.1530/EC-19-0096
doi: 10.1530/EC-19-0096
Giacomini A, Chiesa M, Carraro P (2015) Urgent thyroid-stimulating hormone testing in emergency medicine: a useful tool? J Emerg Med 49:481–487. https://doi.org/10.1016/j.jemermed.2015.05.003
doi: 10.1016/j.jemermed.2015.05.003 pubmed: 26153028
Pimentel L, Hansen KN (2005) Thyroid disease in the emergency department: a clinical and laboratory review. J Emerg Med 28:201–209. https://doi.org/10.1016/j.jemermed.2004.08.020
doi: 10.1016/j.jemermed.2004.08.020 pubmed: 15707817
Buccelletti F, Carroccia A, Marsiliani D, Gilardi E, Silveri NG, Franceschi F (2011) Utility of routine thyroid-stimulating hormone determination in new-onset atrial fibrillation in the ED. Am J Emerg Med 29:1158–1162. https://doi.org/10.1016/j.ajem.2010.06.010
doi: 10.1016/j.ajem.2010.06.010 pubmed: 20708873
Kornelius E, Chiou JY, Yang YS, Peng CH, Lai YR, Huang CN (2015) Iodinated contrast media increased the risk of thyroid dysfunction: a 6-Year retrospective cohort study. J Clin Endocrinol Metab 100:3372–3379. https://doi.org/10.1210/JC.2015-2329
doi: 10.1210/JC.2015-2329 pubmed: 26168278
Bourcier S, Coutrot M, Kimmoun A, Sonneville R, de Montmollin E, Persichini R, Schnell D, Charpentier J, Aubron C, Morawiec E, Bigé N, Nseir S, Terzi N, Razazi K, Azoulay E, Ferré A, Tandjaoui-Lambiotte Y, Ellrodt O, Hraiech S, Delmas C, Barbier F, Lautrette A, Aissaoui N, Repessé X, Pichereau C, Zerbib Y, Lascarrou JB, Carreira S, Reuter D, Frérou A, Peigne V, Fillatre P, Megarbane B, Voiriot G, Combes A, Schmidt M (2020) Thyroid storm in the ICU: a retrospective multicenter study. Crit Care Med 48:83–90. https://doi.org/10.1097/CCM.0000000000004078
doi: 10.1097/CCM.0000000000004078 pubmed: 31714398
Biondi B, Bartalena L, Cooper DS, Hegedüs L, Laurberg P, Kahaly GJ (2015) The 2015 European thyroid association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism. Eur Thyroid J 4:149–163. https://doi.org/10.1159/000438750
doi: 10.1159/000438750 pubmed: 26558232 pmcid: 4637513
Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RP, Rosenthal MS, Sawka AM (2014) American thyroid association task force on thyroid hormone replacement guidelines for the treatment of hypothyroidism: prepared by the American thyroid association task force on thyroid hormone replacement. Thyroid 24:1670–1751. https://doi.org/10.1089/thy.2014.0028
doi: 10.1089/thy.2014.0028 pubmed: 25266247 pmcid: 4267409
Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, Wemeau JL (2013) 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J 2:215–228. https://doi.org/10.1159/000356507
doi: 10.1159/000356507 pubmed: 24783053 pmcid: 3923601
Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M (2018) 2018 European thyroid association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J 7:55–66. https://doi.org/10.1159/000486957
doi: 10.1159/000486957 pubmed: 29594056 pmcid: 5869486
Van den Berghe G (2014) Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid 24:1456–1465. https://doi.org/10.1089/thy.2014.0201
doi: 10.1089/thy.2014.0201 pubmed: 24845024 pmcid: 4195234
Bhakri HL, Fisher R, Khadri A, MacMahon DG (1990) Longitudinal study of thyroid function in acutely ill elderly patients using a sensitive TSH assay-defer testing until recovery. Gerontology 36:140–144. https://doi.org/10.1159/000213189
doi: 10.1159/000213189 pubmed: 2121624
Nolte W, Muller R, Siggelkow H, Emrich D, Hufner M (1996) Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: a randomized study. Eur J Endocrinol 134:337–341. https://doi.org/10.1530/eje.0.1340337
doi: 10.1530/eje.0.1340337 pubmed: 8616532
Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW (2006) Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295:1033–1041. https://doi.org/10.1001/jama.295.9.1033
doi: 10.1001/jama.295.9.1033 pubmed: 16507804 pmcid: 1387822
Baumgartner C, da Costa BR, Collet TH, Feller M, Floriani C, Bauer DC, Cappola AR, Heckbert SR, Ceresini G, Gussekloo J, den Elzen WPJ, Peeters RP, Luben R, Völzke H, Dörr M, Walsh JP, Bremner A, Iacoviello M, Macfarlane P, Heeringa J, Stott DJ, Westendorp RGJ, Khaw KT, Magnani JW, Aujesky D, Rodondi N (2017) Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation. Circulation 136:2100–2116. https://doi.org/10.1161/CIRCULATIONAHA.117.028753
doi: 10.1161/CIRCULATIONAHA.117.028753 pubmed: 29061566 pmcid: 5705446
Biondi B (2012) Mechanisms in endocrinology: heart failure and thyroid dysfunction. Eur J Endocrinol 167:609–618. https://doi.org/10.1530/EJE-12-0627
doi: 10.1530/EJE-12-0627 pubmed: 22956554
Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, Galofré JC (2014) The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab 99:923–931. https://doi.org/10.1210/jc.2013-2409
doi: 10.1210/jc.2013-2409 pubmed: 24423323
Hudzik B, Zubelewicz-Szkodzińska B (2014) Radiocontrast-induced thyroid dysfunction: is it common and what should we do about it? Clin Endocrinol 80:322–327. https://doi.org/10.1111/cen.12376
doi: 10.1111/cen.12376
Somwaru LL, Arnold AM, Joshi N, Fried LP, Cappola AR (2009) High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J Clin Endocrinol Metab 94:1342–1345. https://doi.org/10.1210/jc.2008-1696
doi: 10.1210/jc.2008-1696 pubmed: 19126628 pmcid: 2682480
Lage MJ, Espaillat R, Vora J, Hepp Z (2020) Hypothyroidism treatment among older adults: evidence from a claims database. Adv Ther. 37:2275-2287. https://doi.org/10.1007/s12325-020-01296-z
doi: 10.1007/s12325-020-01296-z pubmed: 32279175 pmcid: 7467444
Lillevang-Johansen M, Abrahamsen B, Jørgensen HL, Brix TH, Hegedüs L (2019) Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk. Eur J Endocrinol 180:407–416. https://doi.org/10.1530/EJE-19-0006
doi: 10.1530/EJE-19-0006 pubmed: 31035256
Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D’Agostino RB (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249–1252. https://doi.org/10.1056/NEJM199411103311901
doi: 10.1056/NEJM199411103311901 pubmed: 7935681
Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, Iervasi G, Åsvold BO, Sgarbi JA, Völzke H, Gencer B, Maciel RM, Molinaro S, Bremner A, Luben RN, Maisonneuve P, Cornuz J, Newman AB, Khaw KT, Westendorp RG, Franklyn JA, Vittinghoff E, Walsh JP, Rodondi N (2012) Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 172:799–809. https://doi.org/10.1001/archinternmed.2012.402
doi: 10.1001/archinternmed.2012.402 pubmed: 22529182
Premawardhana LD (2017) Thyroid testing in acutely ill patients may be an expensive distraction. Biochem Med 27:300–307. https://doi.org/10.11613/BM.2017.033
doi: 10.11613/BM.2017.033
Adlan MA, Neel V, Lakra SS, Bondugulapati LN, Premawardhana LD (2011) Targeted thyroid testing in acute illness: achieving success through audit. J Endocrinol Invest 4:e210–e213. https://doi.org/10.3275/7480
doi: 10.3275/7480
Bridwell RE, Willis GC, Gottlieb M, Koyfman A, Long B (2021) Decompensated hypothyroidism: a review for the emergency clinician. Am J Emerg Med 39:207–212. https://doi.org/10.1016/j.ajem.2020.09.062
doi: 10.1016/j.ajem.2020.09.062 pubmed: 33039222

Auteurs

Irene Campi (I)

Department of Endocrine and Metabolic Diseases, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Auxologico Italiano, San Luca Hospital, Piazzale Brescia 20, 20149, Milan, Italy. i.campi@auxologico.it.

Giovanni Battista Perego (GB)

Department of Cardiovascular, Neural and Metabolic Sciences, IRCCS Istituto Auxologico Italiano, San Luca Hospital, Milan, Italy.

Antonella Ravogli (A)

Department of Cardiovascular, Neural and Metabolic Sciences, IRCCS Istituto Auxologico Italiano, San Luca Hospital, Milan, Italy.

Francesca Santafede (F)

IT Service Management, IRCCS Istituto Auxologico Italiano, Milan, Italy.

Federica Sileo (F)

Department of Endocrine and Metabolic Diseases, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Auxologico Italiano, San Luca Hospital, Piazzale Brescia 20, 20149, Milan, Italy.

Antonella Dubini (A)

Department of Laboratory Medicine, IRCCS Istituto Auxologico Italiano, Milan, Italy.

Gianfranco Parati (G)

Department of Cardiovascular, Neural and Metabolic Sciences, IRCCS Istituto Auxologico Italiano, San Luca Hospital, Milan, Italy.
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Luca Persani (L)

Department of Endocrine and Metabolic Diseases, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Auxologico Italiano, San Luca Hospital, Piazzale Brescia 20, 20149, Milan, Italy.
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.

Laura Fugazzola (L)

Department of Endocrine and Metabolic Diseases, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Auxologico Italiano, San Luca Hospital, Piazzale Brescia 20, 20149, Milan, Italy.
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH